Thermo Fisher ScientificRegister for a premium account to gain access to Sterling AI.
Get StartedThings you can ask Sterling:
Thermo Fisher ScientificLife-science tools group whose Patheon pharma services arm runs what the company calls the largest sterile fill-finish CDMO network. Acquired Sanofi's Ridgefield, NJ sterile fill-finish site in September 2025 and is investing about $1B across 60 CDMO sites in 2026, adding prefilled syringe, cartridge, and autoinjector assembly lines.
All metrics are vertically resized to show how they've changed over time. They're not on the same Y-axis. This chart is meant to compare trends, not values.
Values normalized to 0-100 scale for comparison. Hover for actual values.